News
AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...
In 2022, a study published by Dr. Hawkins and her colleagues at Christian Medical College in Vellore, India, demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback